Primary effusion lymphoma involving both pleural and abdominal cavities in a patient with hepatitis B virus-related liver cirrhosis

Journal of the Formosan Medical Association

Volumn 106, Issue 6, 2007, Pages 504-508

  Hsieh, Pei Ying ^a   Huang, Sheng I ^a   Li, Dian Kun ^a   Mao, Tsui Lien ^a   Sheu, Jin Chuan ^a   Chen, Chien Hung ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Hepatitis B virus; Liver cirrhosis; Primary effusion lymphoma

Indexed keywords

ADEFOVIR; ALANINE AMINOTRANSFERASE; ANTIBIOTIC AGENT; BILIRUBIN; CREATININE; CYCLOPHOSPHAMIDE; DOXORUBICIN; GRANULOCYTE COLONY STIMULATING FACTOR; HEPATITIS B ANTIGEN; HEPATITIS C ANTIGEN; LACTATE DEHYDROGENASE; LAMIVUDINE; PICIBANIL; PREDNISOLONE; VINCRISTINE;

ABDOMINAL DISTENSION; ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASCITES; BACTERIAL PERITONITIS; BILIRUBIN BLOOD LEVEL; BIOCHEMISTRY; CASE REPORT; CLINICAL ASSESSMENT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CREATININE BLOOD LEVEL; CYTOGENETICS; CYTOLOGY; DRUG WITHDRAWAL; ECHOGRAPHY; FEBRILE NEUTROPENIA; FOLLOW UP; HEPATIC ENCEPHALOPATHY; HEPATITIS B; HEPATITIS B VIRUS; HEPATORENAL SYNDROME; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOALBUMINEMIA; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; KIDNEY DISEASE; LACTATE DEHYDROGENASE BLOOD LEVEL; LIVER CIRRHOSIS; LIVER FAILURE; LIVER FUNCTION; MALE; MORTALITY; NORMOCHROMIC NORMOCYTIC ANEMIA; NUCLEAR MAGNETIC RESONANCE IMAGING; PERITONEAL CAVITY; PLEURA CAVITY; POLYMERASE CHAIN REACTION; PRIMARY EFFUSION LYMPHOMA; PROTHROMBIN TIME; SEPSIS; SPLENOMEGALY; TREATMENT OUTCOME;

EID: 34447340214     PISSN: 09296646     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0929-6646(09)60302-8     Document Type: Article

References (25)

1. Nador RG, Cesarman E, Chadburn A, et al. Primary effusion lymphoma: a distinct clinicopathologic entity associated with the Kaposi's sarcoma-associated herpesvirus. Blood 1996;88:645-56.
2. Boulanger E, Agbalika F, Maarek O, et al. A clinical, molecular and cytogenetic study of 12 cases of human herpesvirus 8 associated with primary effusion lymphoma in HIV-infected patients. Hematol J 2001;2:172-9.
3. Ely SA, Powers J, Lewis D, et al. Kaposi's sarcoma-associated herpes virus-positive primary effusion lymphoma arising in the subarachnoid space. Hum Pathol 1999;30:981-4
4. Klepfish A, Sarid R, Shtalrid M, et al. Primary effusion lymphoma (PEL) in HIV-negative patients - a distinct clinical entity. Leuk Lymphoma 2001;41:439-43.
5. Ascoli V, Lo Coco F, Artini M, et al. Primary effusion Burkitts lymphoma with t(8;22) in a patient with hepatitis C virus-related cirrhosis. Hum Pathol 1997;28:101-4.
6. Paner GP, Jensen J, Foreman KE, et al. HIV and HHV-8 negative primary effusion lymphoma in a patient with hepatitis C virus-related liver cirrhosis. Leuk Lymphoma 2003 44:1811-4.
7. Carbone A, Gloghini A, Vaccher E, et al. Kaposi's sarcoma-associated herpesvirus/human herpesvirus type 8-positive solid lymphomas: a tissue-based variant of primary effusion lymphoma. J Mol Diagn 2005;7:17-27.
8. Iuchi K, Ichimiya A, Akashi A, et al. Non-Hodgkin's lymphoma of the pleural cavity developing from long-standing pyothorax. Cancer 1987;60:1771-5.
9. DePond W, Said JW, Tasaka T, et al. Kaposi's sarcoma-associated herpesvirus and human herpesvirus 8 (KSHV/HHV8)-associated lymphoma of the bowel. Report of two cases in HIV-positive men with secondary effusion lymphomas. Am J Surg Pathol 1997;21:719-24.
10. Chan AC, Chan JK, Yan KW, et al. Anaplastic large cell lymphoma presenting as a pleural effusion and mimicking primary effusion lymphoma. A report of 2 cases. Acta Cytol 2003;47:809-16.
11. Gaidano G, Gloghini A, Gattei V, et al. Association of Kaposi's sarcoma-associated herpesvirus-positive primary effusion lymphoma with expression of the CD138/syndecan-1 antigen. Blood 1997; 90:4894-900.
12. Carbone A, Gloghini A, Cozzi MR, et al. Expression of MUM1/IRF4 selectively clusters with primary effusion lymphoma among lymphomatous effusions: implications for disease histogenesis and pathogenesis. Br J Haematol 2000;111:247-57.
13. Teruya-Feldstein J, Zauber P, Setsuda JE, et al. Expression of human herpesvirus-8 oncogene and cytokine homologues in an HIV-seronegative patient with multicentric Castleman's disease and primary effusion lymphoma. Lab Invest 1998;78:1637-42.
14. Boulanger E, Hermine O, Fermand JP, et al. Human herpesvirus 8 (HHV-8)-associated peritoneal primary effusion lymphoma (PEL) in two HIV-negative elderly patients. Am J Hematol 2004;76:88-91.
15. Ascoli V, Lo-Coco F. Body cavity lymphoma. Curr Opin Pulm Med 2002;8:317-22.
16. Nakamura Y, Tajima F, Omura H, et al. Primary effusion lymphoma of the left scrotum. Intern Med 2003;42: 351-3.
17. Huang LM, Huang SY, Chen MY, et al. Geographical differences in human herpesvirus 8 seroepidemiology: a survey of 1,201 individuals in Asia. J Med Virol 2000;60:290-3.
18. Waddington TW, Aboulafia DM. Failure to eradicate AIDS-associated primary effusion lymphoma with high-dose chemotherapy and autologous stem cell reinfusion: case report and literature review. AIDS Patient Care STDS 2004;18:67-73.
19. Boulanger E, Daniel MT, Agbalika F, et al. Combined chemotherapy including high-dose methotrexate in KSHV/HHV8-associated primary effusion lymphoma. Am J Hematol 2003;73:143-8.
20. Ghosh SK, Wood C, Boise LH, et al. Potentiation of TRAIL-induced apoptosis in primary effusion lymphoma through azidothymidine-mediated inhibition of NF-kappa B. Blood 2003;101:2321-7.
21. Inoue Y, Tsukasaki K, Nagai K, et al. Durable remission by sobuzoxane in an HIV-seronegative patient with human herpesvirus 8-negative primary effusion lymphoma. Int J Hematol 2004;79:271-5.
22. Klass CM, Offermann MK. Targeting human herpesvirus-8 for treatment of Kaposi's sarcoma and primary effusion lymphoma. Curr Opin Oncol 2005;17:447-55.
23. Cannon M, Cesarman E, Boshoft C. KSHV G protein-coupled receptor inhibits lytic gene transcription in primary-effusion lymphoma cells via p21-mediated inhibition of Cdk2. Blood 2006;107:277-84.
24. Dienstag JL, Schiff ER, Wright TL, et al. Lamivudine as initial treatment for chronic hepatitis B in the United States. N Engl J Med 1999;341:1256-63.
25. Hadziyannis SJ, Tassopoulos NC, Heathcote EJ, et al. Adefovir dipivoxil for the treatment of hepatitis B e antigen-negative chronic hepatitis B. N Engl J Med 2003;348: 800-7.